any opinions on burzynskis antineoplastons or information about the current status of his research would be appreciatedburzynskis work is not too promising none of his a1 through aantineoplastons have been shown to have antineoplastic effects againsexperimental cancer the nci conducted tests of a2 and a5 againsleukemia in mice with the result that doses high enough to productoxic effects in the mice were not effective in inhibiting the growtof the tumor or killing it these were in 1983 and 1985burzynski claims that a10 is the active factor common to all of aand a5 something which he has not shown a10 has only beeextracted from a2 he also hasnt shown that a1 through a5 are actualldistinct substances the nci conducted a series of tests using a1against a standard panel of tumors that included different cell linefrom tumors in the following classes leukemia nonsmallcell ansmallcell lung cancer colon cancer cancer of the central nervousystem melanoma ovarian cancer and renal cancer a10 exhibiteneither growth inhibition nor cytotoxicity at the dose levels testedit is necessary to process a10 since it is not soluble burzynskitheory requires soluble agents but this basically hydrolizes it tpag which he calls as 25 pag is not an information carryinpeptide something which byrzynski claims is necessary foantineoplastic activity as 21 also derived from a10 is a 4mixture of pa and pag pa also not a peptide can be purchased at chemical supply houses for about 009 a gram a10 is chemicallextremely similar to glutithamide and thalidomide both of which arhabit forming and can cause peripheral neuropathy the nasty effectof thalidomide are widely known in spite of this similarity a1does not appear to have been tested for its potential to inducteratogenicity or peripheral neuropathymany of burzynskis statements about the origin of his theory earlresearch past and present support by others for his work have beeshown to be untruesdsdbssrco
